EQUINOX NEPREMICNINE D.D. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57 EUR | +7.55% |
|
0.00% | +8.57% |
| 2022 | An unknown buyer acquired an unknown minority stake in EQUINOX NEPREMICNINE d.d. from Axor holding d.d. | CI |
| 2022 | EQUINOX NEPREMICNINE d.d. has completed an IPO. | CI |
Evolution of the average Target Price on EQUINOX NEPREMICNINE d.d.
Price target over the last 5 years
History of analyst recommendation changes
763f9682.ZztcydmQiyo7ciglSPWERhm0FBKFmhmDKJBCW1aw4Go.UgIVpezP30lyGEFhHJrCMm7TcSTE3UDZcfUxLzPZpgYrdDeI79LaeE1GeQ~fb7584aac89ced2b7b20b28514da67cc
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
57
EUR
Average target price
63.5
EUR
Spread / Average Target
+11.40%
High Price Target
63.5
EUR
Spread / Highest target
+11.40%
Low Price Target
63.5
EUR
Spread / Lowest Target
+11.40%
Consensus detail
Consensus revision (last 18 months)
Annual profits - Rate of surprise
- Stock Market
- Equities
- EQNX Stock
- Consensus EQUINOX NEPREMICNINE d.d.
